MENU
CVAC
AS OF
Dec 12 closing price
Price
$5.05
Change
-$0.07 (-1.37%)
Capitalization
1.14B
136 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
CVAC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

CureVac (CVAC) Ownership - Who owns CureVac?

CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people... Show more

#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.14B
P/E Ratio
7.57
Total Cash
419.21M
Projected Growth
N/A
Total Debt
35.07M
Revenue
70.74M
Risk (Beta)
2.42
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
0.37 USD as % of share price

Fundamentals

CVAC
Capitalization
1.14B
P/E Ratio
7.57
Risk (Beta)
2.42
Dividend Yield
N/A
Total Cash
419M
Total Cash/Share
1.86
Total Debt
35.1M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.37%
Revenue
70.7M
ROE
N/A
Book Value
871M
P/B Ratio
1.12
Cash Flow
N/A
Earnings
0.57
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
27M
Current Ratio
3.70
Current Revenue Per Employee
49755.52
Dividends Per Share - Security
N/A
EBITDA
181M
Float
N/A
Float - Current
N/A
Gross Income Margin
99.31
Revenue To Assets
12.93
Shares Held By Institutions
148M
Shares Outstanding - Current
225M
Total Liabilities
267M
Total Volume MTD
N/A
Value
N/A
Gain YTD
50.147
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CVAC
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CVAC showed earnings on November 24, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CVAC
A.I. Advisor
published General Information

General Information

a clinical-stage biopharmaceutical company developing tumour immunotherapy

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
Friedrich-Miescher-Strasse 15
Phone
+49 707198830
Employees
1049
Web
https://www.curevac.com